Funder
National Center for Advancing Translational Sciences
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference27 articles.
1. van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus Bacteremia. Clin. Microbiol. Rev. [Internet] 2012;25:362–86. https://journals.asm.org/doi/10.1128/CMR.05022-11.10.1128/CMR.05022-11
2. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation [Internet] 2015 13;132:1435–86. http://www.ncbi.nlm.nih.gov/pubmed/26373316d.10.1161/CIR.0000000000000296
3. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children. Clin. Infect. Dis. [Internet] 2011 1;52:e18–55. https://academic.oup.com/cid/article/52/3/e18/306145d.10.1093/cid/ciq146
4. Bidell MR, Patel N, O’Donnell JN. Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins. J. Antimicrob. Chemother. [Internet] 2018;73:2643–51. http://www.ncbi.nlm.nih.gov/pubmed/30085140d.10.1093/jac/dky259
5. Eljaaly K, Alshehri S, Erstad BL. Systematic review and meta-analysis of the safety of antistaphylococcal penicillins compared to cefazolin. Antimicrob. Agents Chemother. [Internet] 2018;62. http://www.ncbi.nlm.nih.gov/pubmed/29437617d.10.1128/AAC.01816-17
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献